Hansoh Pharmaceutical Group 대차 대조표 상태
재무 상태 기준 확인 5/6
Hansoh Pharmaceutical Group 의 총 주주 지분은 CN¥27.9B 이고 총 부채는 CN¥40.3M, 이는 부채 대 자기자본 비율을 0.1% 로 가져옵니다. 총자산과 총부채는 각각 CN¥31.7B 및 CN¥3.8B 입니다. Hansoh Pharmaceutical Group 의 EBIT는 CN¥4.2B 이며 이자보상배율은 -4.1 입니다. CN¥23.5B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
0.1%
부채 비율
CN¥40.26m
부채
| 이자 보상 비율 | -4.1x |
| 현금 | CN¥23.50b |
| 주식 | CN¥27.90b |
| 총 부채 | CN¥3.77b |
| 총 자산 | CN¥31.67b |
최근 재무 상태 업데이트
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Recent updates
Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06재무 상태 분석
단기부채: 3692 의 단기 자산 ( CN¥27.4B )이 단기 부채( CN¥3.4B ).
장기 부채: 3692 의 단기 자산( CN¥27.4B )이 장기 부채( CN¥336.6M ).
부채 대 자본 내역 및 분석
부채 수준: 3692 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: 3692 의 부채 대 자기자본 비율은 지난 5년간 0% 에서 0.1% 로 증가했습니다.
부채 범위: 3692 의 부채는 영업 현금 흐름 ( 11558% )에 의해 잘 충당되었습니다.
이자 보장: 3692 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.